RecruitingNCT05388461
Follow-up after ECT for severe or resistant depression
An observational study follows outcomes, side effects and relapse after ECT received in routine care.
Observational follow-upAges 18+Norway
Understand this study
What is this study about?
This observational registry follows short- and longer-term outcomes after electroconvulsive therapy (ECT), including response, side effects, cognition and relapse.
Who could participate?
Adults treated with ECT for a depressive episode at Haukeland or Stavanger University Hospital after 2013, who give written consent to the regional registry.
What will I do during this study?
People receiving ECT (electroconvulsive therapy) in routine care can consent to the research registry. Patients and clinicians assess depressive symptoms and cognitive function during follow-up.
- Listed locations
- Bergen and 1 more locationSee all locations and recruitment
- Follow-up
- 6 months of follow-up
- Study activities
- Patient and clinician assessments
What to know before participating
Your treatment and care
ECT is received through ordinary clinical care; enrollment in this observational registry does not assign it. Possible cognitive impairment is one of the outcomes being followed.
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: March 13, 2013
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 600
- Sponsor
- Haukeland University Hospital
- Sponsor type
- Hospital / academic medical center
- Study type
- Observational
- Intervention type
- Other
- Locations
- Norway
- Age range
- Over 18 Years
- Official registry ID
- NCT05388461
- Official title
Show the full official title
Acute Efficacy and 6 Months Follow up After Electroconvulsive Therapy for Severe or Treatment Resistant Depression - Predictors of Response, Side Effects, and Relapse
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Bergen · Stavanger
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Haukeland University Hospital, a hospital or academic medical center.
Who can participate?
Listed age limits: from 18 years.
Is this study still recruiting?
The registry lists this study as recruiting.
